IN8bio, Inc. (INAB) Misses Q2 EPS by 2c
IN8bio, Inc. (NASDAQ: INAB) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.
IN8bio, Inc. (NASDAQ: INAB) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.